U.S. Chemicals Stock News

Mercantile Bank (MBWM) just posted another quarter of steady profitability, with Q4 2025 revenue at US$61.8 million and net income of US$22.8 million, which translates into basic EPS of US$1.40 ahead of its Q1 2026 reporting period. Over recent quarters the bank has seen revenue move from US$56.3 million in Q4 2024 to US$61.8 million in Q4 2025, while basic EPS increased from US$1.22 to US$1.40, giving investors a clear picture of consistent earnings power heading into the new year. With...

On April 15, 2026, Organon & Co. reported that VTAMA (tapinarof) cream received a strong, evidence-based recommendation in the American Academy of Dermatology’s first pediatric atopic dermatitis guidelines, which recognize it as the only steroid-free topical supported by high-certainty evidence for children aged 2 and older across all disease severities. This endorsement strengthens VTAMA’s clinical profile in a large pediatric eczema population, potentially reinforcing Organon’s...

Why the AACR data on rinzimetostat is on investors’ radar ORIC Pharmaceuticals (ORIC) shares are in focus after the company highlighted new preclinical data for rinzimetostat at the 2026 AACR Annual Meeting, centered on prostate cancer models that include treatment resistant disease. See our latest analysis for ORIC Pharmaceuticals. ORIC’s latest AACR posters on rinzimetostat arrive after a strong year to date, with a 33.29% year to date share price return and a 123.61% 1 year total...

Over the last 7 days, the United States market has risen by 3.6%, and over the past year, it has seen a remarkable increase of 39%, with earnings forecasted to grow by 16% annually. In such a thriving environment, identifying stocks that are potentially undervalued can offer opportunities for investors looking to capitalize on discrepancies between current prices and estimated worth.

Over the last 7 days, the United States market has risen 3.6%, and over the past year, it has climbed 39%, with earnings expected to grow by 16% annually. Penny stocks may be a throwback term, but they still offer intriguing opportunities for investors seeking growth at lower price points. By focusing on those with strong balance sheets and solid fundamentals, these stocks can present an underappreciated chance for stability and potential upside in today's market conditions.

Gogo Inc. ( NASDAQ:GOGO ), is not the largest company out there, but it received a lot of attention from a substantial...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Investors may be considering whether Universal Health Services offers good value at its current share price, or whether the recent share price move has already reflected much of the opportunity. The stock last closed at US$179.72, with a 1.9% decline over 7 days, a 3.3% decline over 30 days, an 18.3% decline year to date, and a 14.9% gain over the past year. Recent coverage has focused on Universal Health Services as a major player in US healthcare services, with ongoing attention on how...

Ocular Therapeutix (NasdaqGM:OCUL) released new 52-week post hoc Phase 3 data for AXPAXLI in wet age-related macular degeneration. The SOL-1 trial data indicated better durability, strong sustained disease control, and safety outcomes compared to aflibercept. The company presented the findings at a major ophthalmology conference and plans to seek FDA approval with a single pivotal Phase 3 trial. Ocular Therapeutix focuses on therapies for eye diseases, with AXPAXLI (OTX TKI) aimed at...

If you are wondering whether Whirlpool's current share price reflects its true worth, this breakdown will help you see how the market is pricing the business today. The stock last closed at US$57.25, with a recent 2.2% gain over 7 days and 9.5% over 30 days, set against a return of 23.2% decline year to date and 21.4% decline over the past year. Recent attention around Whirlpool has focused on its position in the household appliances market and how investors are weighing that against wider...

The United States market has experienced a notable upswing, climbing 3.6% in the last week and rising 39% over the past year, with earnings projected to grow by 16% annually. In this environment, identifying stocks that may be trading below their estimated intrinsic value can present compelling opportunities for investors seeking to capitalize on potential market inefficiencies.

Agree Realty (NYSE:ADC) has approved increases to both its common and preferred dividends following board authorization. The updated payouts represent a change in the company’s dividend policy that is material for existing and prospective shareholders. These actions follow a period in which the stock has returned 10.3% year to date and 38.7% over 5 years, with the latest close at $79.56. For investors watching dividend income, Agree Realty’s new board-approved increases to both common and...

The United States market has recently experienced a notable upswing, climbing 3.6% in the last week and showing a robust 39% increase over the past year, with earnings projected to grow by 16% annually in the coming years. In this favorable environment, growth companies with high insider ownership can be particularly appealing as they often demonstrate strong confidence from those who know the business best and have vested interests in its success.

The market has shown impressive growth, climbing 3.6% over the last week and 39% in the past year, with earnings forecasted to grow by 16% annually. While the term 'penny stocks' might seem outdated, these stocks continue to offer a unique blend of affordability and potential growth when backed by solid financials. In this article, we explore several penny stocks that stand out for their financial strength and potential as under-the-radar opportunities for investors.

American Well Corporation ( NYSE:AMWL ) shareholders may have reason to be concerned, as several insiders sold their...

Last week, First Watch Restaurant Group, Inc.'s (NASDAQ:FWRG) stock jumped 16%, but insiders who sold US$4.6m worth of...

One thing we could say about the analysts on Monte Rosa Therapeutics, Inc. ( NASDAQ:GLUE ) - they aren't optimistic...

The Morning Bull - US Market Morning Update Tuesday, Apr, 21 2026 US stock futures point higher this morning, with E-mini S&P 500 contracts up about 0.25% and Nasdaq-100 minis up around 0.38%, as investors weigh strong global demand against rising government borrowing costs and inflation worries. Taiwan’s export orders hit a record US$91.1b in March, up 65.9% from a year earlier, which signals powerful demand for electronics and chips that feed into many US tech and manufacturing names. At...

One thing we could say about the analysts on Viridian Therapeutics, Inc. ( NASDAQ:VRDN ) - they aren't optimistic...

While Corsair Gaming, Inc. ( NASDAQ:CRSR ) might not have the largest market cap around , it led the NASDAQGS gainers...

Wondering whether CVR Energy at around US$30.18 still offers value, or if the easy gains are behind it? This article walks through what the recent performance and current pricing might be telling you. The stock has seen a 3.6% decline over the last 7 days and a 10.8% decline over the last 30 days, even though the year to date return is 19.8% and the 1 year return sits at 65.4%. Those moves come after a multi year run in which the 3 year return is 30.9% and the 5 year return is 211.0%. These...

Wondering whether QXO at around US$24.22 is offering value or asking too much of future expectations? This breakdown is designed to help you weigh that up calmly and clearly. The stock has shown sharp moves recently, with returns of 9.1% over 7 days, 29.9% over 30 days, 22.8% year to date, 90.4% over 1 year, 18.4% over 3 years, and a 38.4% decline over 5 years. These mixed returns give important context for thinking about what investors are currently pricing in and how sentiment toward QXO...

How FirstEnergy’s Recent Returns Frame the Valuation Question Before comparing valuation models, it helps to see how FirstEnergy’s share price has behaved over different time frames and what that might signal about how the market currently views the company. Over the last year, FirstEnergy has returned 23.1%, with a year to date return of 9.3%. The shorter term picture is more mixed, with a 1.9% return over the last 30 days and a 3.1% decline over the last week, which can be relevant if you...

Washington Trust Bancorp (WASH) opened 2026 with Q1 revenue of US$53.8 million and basic EPS of US$0.66, alongside trailing twelve month revenue of US$215.8 million and EPS of US$2.75 that reflect a return to profit. Over recent quarters the company has seen revenue move from US$57.9 million in Q1 2025 to US$53.8 million in Q1 2026, while quarterly EPS has ranged between US$0.57 and US$0.84. This gives investors a clearer read on how current margins are holding up against last year’s...